Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti-PD-1 therapy

Cancer Commun (Lond). 2025 Jan;45(1):58-62. doi: 10.1002/cac2.12631. Epub 2024 Nov 20.
No abstract available

Publication types

  • Letter